Enzymatic blood group conversion of human kidneys during <i>ex vivo</i> normothermic machine perfusion

Serena MacMillan, Sarah A. Hosgood, Michael L. Nicholson

British journal of surgery · 2022 · 25 citations · 9 references

DOIFull text

Open access

Concepts

Abstract

A major restriction to transplantation is the requirement for ABO blood group compatibility between donor and recipient. In this study, an α-galactosidase enzyme from Bacteroides fragilis was used successfully to remove type B blood group antigens enzymatically from human kidneys using ex vivo normothermic machine perfusion. This provides the first step for a strategy to overcome the ABO barrier in kidney transplantation.

References

9